Cervicitis

• CLINICAL_TRIALS trial_result · 2025-09-23
  Clinical Trial Update: Rapid Diagnostic Assay for Gonorrhea and Chlamydia [NA]

  Massachusetts General Hospital completed a clinical trial evaluating a rapid diagnostic assay for gonorrhea and chlamydia; results have been…

• FDA approval · 2020-01-28
  FDA Approved: AZITHROMYCIN — Original Application (Alembic Pharmaceuticals Limited)

  FDA approves Alembic Pharmaceuticals' original application for AZITHROMYCIN, granting a generic azithromycin product for the same indication…

• FDA approval · 2020-01-23
  FDA Approved: AZITHROMYCIN — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for azithromycin filed by Aurobindo Pharma Limited.

• FDA approval · 2018-09-24
  FDA Approved: AZITHROMYCIN DIHYDRATE — Original Application (Precision Dose, Inc.)

  FDA approved azithromycin dihydrate as a generic drug under Original Application by Precision Dose, Inc., expanding access to this antibioti…

• FDA approval · 2018-07-05
  FDA Approved: AZITHROMYCIN — Original Application (Aurobindo Pharma Limited)

  FDA approved a generic azithromycin product under an Original ANDA for Aurobindo Pharma Limited.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2016-07-12
  Clinical Trial Update: "Performance of HPV DNA Test in Presence of Co-infection With Common RTIs" [NA]

  A clinical trial investigates the performance of an HPV DNA test in the presence of co-infection with common reproductive tract infections, …

• CLINICAL_TRIALS trial_result · 2014-12-15
  Clinical Trial Update: Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced [Phase 4]

  A Phase 4 clinical trial update reports on the time to eradication of Mycoplasma genitalium and Chlamydia trachomatis after treatment, in in…

• FDA approval · 2012-12-18
  FDA Approved: AZITHROMYCIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for azithromycin submitted by Teva Pharmaceuticals USA, Inc.

• CLINICAL_TRIALS trial_result · 2012-10-25
  Clinical Trial Update: Empiric Therapy of Mucopurulent Cervicitis (MPC) [Phase 3]

  Phase 3 trial evaluating empiric therapy for mucopurulent cervicitis was terminated, with results posted in 2012.